1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 11, 2010, Pages 4714-4722

  Rinaldo, Christine Hanssen ^a   Gosert, Rainer ^b   Bernhoff, Eva ^a   Finstad, Solrun ^a   Hirsch, Hans H ^b,c  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CIDOFOVIR; CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; VIRUS LARGE T ANTIGEN;

ARTICLE; BK VIRUS; CELL ADHESION; CELL METABOLISM; CELL PROLIFERATION; CELL VIABILITY; DNA REPLICATION; DRUG DOSE TITRATION; DRUG INHIBITION; EPITHELIUM CELL; GENE EXPRESSION; HOST CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; KIDNEY TUBULE CELL; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENE; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION; WESTERN BLOTTING;

ANTIVIRAL AGENTS; BK VIRUS; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYTOSINE; HUMANS; MICROSCOPY, FLUORESCENCE; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

EID: 78049268991     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00974-10     Document Type: Article

References (33)

1. Bernhoff, E., T. J. Gutteberg, K. Sandvik, H. H. Hirsch, and C. H. Rinaldo. 2008. Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression. Am. J. Transplant. 8:1413-1422.
2. Bernhoff, E., G. D. Tylden, L. J. Kjerpeseth, T. J. Gutteberg, H. H. Hirsch, and C. H. Rinaldo. 2010. Leflunomide inhibition of BK virus replication in renal tubular epithelial cells. J. Virol. 84:2150-2156.
3. Binet, I., V. Nickeleit, H. H. Hirsch, O. Prince, P. Dalquen, F. Gudat, M. J. Mihatsch, and G. Thiel. 1999. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 67:918-922.
4. Binggeli, S., A. Egli, S. Schaub, I. Binet, M. Mayr, J. Steiger, and H. H. Hirsch. 2007. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am. J. Transplant. 7:1131-1139.
5. Cole, C. N. 1996. Polyomavirinae: the viruses and their replication, p. 917-945. In D. M. K. Bernard, N. Fields, and Peter M. Howley (ed.), Fundamental virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, PA.
6. Comoli, P., A. Azzi, R. Maccario, S. Basso, G. Botti, G. Basile, I. Fontana, M. Labirio, A. Cometa, F. Poli, F. Perfumo, F. Locatelli, and F. Ginevri. 2004. Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 78:1229-1232.
7. Dropulic, L. K., and R. J. Jones. 2008. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant. 41:11-18.
8. Egli, A., L. Infanti, A. Dumoulin, A. Buser, J. Samaridis, C. Stebler, R. Gosert, and H. H. Hirsch. 2009. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J. Infect. Dis. 199: 837-846.
9. Farasati, N. A., R. Shapiro, A. Vats, and P. Randhawa. 2005. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 79:116-118.
10. Funk, G. A., R. Gosert, P. Comoli, F. Ginevri, and H. H. Hirsch. 2008. Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants. Am. J. Transplant. 8:2368-2377.
11. Gosert, R., C. H. Rinaldo, G. A. Funk, A. Egli, E. Ramos, C. B. Drachenberg, and H. H. Hirsch. 2008. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J. Exp. Med. 205:841-852.
12. Hardinger, K. L., M. J. Koch, D. J. Bohl, G. A. Storch, and D. C. Brennan. 2010. BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am. J. Transplant. 10:407-415.
13. Hirsch, H. H. 2005. BK virus: opportunity makes a pathogen. Clin. Infect. Dis. 41:354-360.
14. Hirsch, H. H. 2010. Polyoma and papilloma virus infections after hematopoietic stem cell or solid organ transplantation, p. 465-482. In P. Bowden, P. Ljungman, and D. R. Snydman (ed.), Transplant infections, 3rd ed. Lippincott Williams & Wilkins, Philadelphia, PA.
15. Hirsch, H. H., D. C. Brennan, C. B. Drachenberg, F. Ginevri, J. Gordon, A. P. Limaye, M. J. Mihatsch, V. Nickeleit, E. Ramos, P. Randhawa, R. Shapiro, J. Steiger, M. Suthanthiran, and J. Trofe. 2005. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79:1277-1286.
16. Hirsch, H. H., M. Mohaupt, and T. Klimkait. 2001. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J. Infect. Dis. 184:1494-1496.
17. Hirsch, H. H., and J. Steiger. 2003. Polyomavirus BK. Lancet Infect. Dis. 3:611-623.
18. Hostetler, K. Y. 2009. Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art. Antiviral Res. 82:A84-98.
19. Kuypers, D. R., B. Bammens, K. Claes, P. Evenepoel, E. Lerut, and Y. Vanrenterghem. 2009. A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients. J. Antimicrob. Chemother. 63:417-419.
20. Kuypers, D. R., A. K. Vandooren, E. Lerut, P. Evenepoel, K. Claes, R. Snoeck, L. Naesens, and Y. Vanrenterghem. 2005. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am. J. Transplant. 5:1997-2004.
21. Low, J., H. D. Humes, M. Szczypka, and M. Imperiale. 2004. BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology 323:182-188.
22. Olsen, G. H., H. H. Hirsch, and C. H. Rinaldo. 2009. Functional analysis of polyomavirus BK non-coding control region quasispecies from kidney transplant recipients. J. Med. Virol. 81:1959-1967.
23. Painter, G. R., and K. Y. Hostetler. 2004. Design and development of oral drugs for the prophylaxis and treatment of smallpox infection. Trends Biotechnol. 22:423-427.
24. Polo, C., J. L. Perez, A. Mielnichuck, C. G. Fedele, J. Niubo, and A. Tenorio. 2004. Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. Clin. Microbiol. Infect. 10:640-644.
25. Ramos, E., C. B. Drachenberg, J. C. Papadimitriou, O. Hamze, J. C. Fink, D. K. Klassen, R. C. Drachenberg, A. Wiland, R. Wali, C. B. Cangro, E. Schweitzer, S. T. Bartlett, and M. R. Weir. 2002. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J. Am. Soc Nephrol. 13:2145-2151.
26. Ramos, E., C. B. Drachenberg, R. Wali, and H. H. Hirsch. 2009. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation 87:621-630.
27. Randhawa, P., N. A. Farasati, R. Shapiro, and K. Y. Hostetler. 2006. Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro. Antimicrob. Agents Chemother. 50:1564-1566.
28. Randhawa, P. S., S. Finkelstein, V. Scantlebury, R. Shapiro, C. Vivas, M. Jordan, M. M. Picken, and A. J. Demetris. 1999. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 67: 103-109.
29. Randhawa, P. S., K. Khaleel-Ur-Rehman, P. A. Swalsky, A. Vats, V. Scantlebury, R. Shapiro, and S. Finkelstein. 2002. DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation 73:1090-1094.
30. Randhawa, P. S., A. Vats, D. Zygmunt, P. Swalsky, V. Scantlebury, R. Shapiro, and S. Finkelstein. 2002. Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation 74: 485-488.
31. Rinaldo, C. H., and H. H. Hirsch. 2007. Antivirals for the treatment of polyomavirus BK replication. Expert Rev. Anti Infect. Ther. 5:105-115.
32. Rinaldo, C. H., T. Traavik, and A. Hey. 1998. The agnogene of the human polyomavirus BK is expressed. J. Virol. 72:6233-6236.
33. Seemayer, C. A., N. H. Seemayer, U. Durmuller, F. Gudat, S. Schaub, H. H. Hirsch, and M. J. Mihatsch. 2008. BK virus large T and VP-1 expression in infected human renal allografts. Nephrol. Dial Transplant. 23:3752-3761.